Cargando…

Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) has been associated with worse prognoses due to the limited treatment options. Thus, there is a need to characterise new biomarkers or treatment targets to improve patient outcomes. Cancer testis antigens (CTAs) are a group of antigens that are pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Runyi Adeline, Tien, Tracy Zhijun, Joseph, Craig Ryan, Lim, Johnathan Xiande, Thike, Aye Aye, Iqbal, Jabed, Tan, Puay Hoon, Yeong, Joe Poh Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345750/ https://www.ncbi.nlm.nih.gov/pubmed/34359776 http://dx.doi.org/10.3390/cancers13153875

Ejemplares similares

Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer
por: Ong, Chong Hui Clara, et al.
Publicado: (2022)

Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients
por: Gole, Laurent, et al.
Publicado: (2020)

More microinvasive foci in larger tumours of breast ductal carcinoma in situ
por: Chen, Xiao-Yang, et al.
Publicado: (2022)

High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
por: Yeong, Joe, et al.
Publicado: (2018)

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
por: Yeong, Joe, et al.
Publicado: (2019)

Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer
por: Tay, Timothy Kwang Yong, et al.
Publicado: (2018)

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
por: Teng, Yvonne Hui-Fang, et al.
Publicado: (2011)

Medullary breast carcinoma: a pathogenic review and immunohistochemical study using tissue microarray
por: Lee, Ming, et al.
Publicado: (2021)

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers—Analytical validation and performance evaluation with clinical samples
por: Ng, Cedric Chuan-Young, et al.
Publicado: (2022)

CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
por: Chong, Tsung Wen, et al.
Publicado: (2015)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
por: Naik, Adviti, et al.
Publicado: (2022)

Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers
por: Lau, Hannah Si Hui, et al.
Publicado: (2023)

A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions
por: Tan, Wai Jin, et al.
Publicado: (2016)

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
por: Ghose, Soumya, et al.
Publicado: (2023)

GRAM domain-containing protein 1B (GRAMD1B), a novel component of the JAK/STAT signaling pathway, functions in gastric carcinogenesis
por: Khanna, Puja, et al.
Publicado: (2017)

Epigenetic derepression converts PPARγ into a druggable target in triple-negative and endocrine-resistant breast cancers
por: Loo, Ser Yue, et al.
Publicado: (2021)

Cancer testis antigen expression in triple negative breast cancer: Candidate targets for cancer immunotherapy?
por: Hendrickx, Wouter, et al.
Publicado: (2015)

In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens
por: Parvizpour, Sepideh, et al.
Publicado: (2019)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2019)

p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6
por: Phalke, Sameer, et al.
Publicado: (2012)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy
por: Mirandola, Leonardo, et al.
Publicado: (2017)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles
por: Kannan, Anbarasu, et al.
Publicado: (2020)

Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report
por: Tay, Timothy Kwang Yong, et al.
Publicado: (2022)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
por: Kim, Ye-Rin, et al.
Publicado: (2021)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Dibutyltin Dichloride Retards Leydig Cell Developmental Regeneration in Adult Rat Testis
por: Huang, Xiande, et al.
Publicado: (2018)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_35hp6sb347d0f3hjfe82fs69gg